A Cure in Sight is joined by Dr. Richard Carvajal for a medical webinar-style discussion on: 
- how to understand the data behind a clinical trial?
- What the decision making process can look like for managing surveillance, ahead of metastatic discovery, or after and what components go into that process?
- Recommended scan protocol from uveal melanoma oncology teams and how they differ and why
 
Come prepared with questions and an enlightening and empowering discussion.
 
A little about Dr. Carvajal: 
"Richard D. Carvajal, MD is an Associate Professor of Medicine at Columbia University Irving Medical Center where he serves as both Director of Experimental Therapeutics and Director of the Melanoma Service within the  Division of Hematology/Oncology. He serves as Co-Leader of the Precision Oncology and Systems Biology Program within the Herbert Irving Comprehensive Cancer Center. Dr. Carvajal’s research is focused on the development of novel therapies for patients with melanoma [including uveal melanoma] and other cancers, with the overall objective of controlling and curing these diseases."

ANNOUNCEMENTS:

EYE GIVE for Giving Tuesday is open for registration!
FB fundraising is currently down for all non-profits--help us out by joining the "Eye Give" movement through this link!

Steps for Sight Registration is coming! Subscribe to the newsletter to stay in the know!
 
Email contact@acureinsight.org for questions regarding any upcoming events!

*********
Be sure to follow us on Facebook, Twitter, Linked In, or  Instagram @acureinsight, for more stories, tips, research news, and ideas to help you navigate this journey with OM!
*A Cure in Sight is a 501c3 organization. All donations made can help fund our podcast to educate patients, fund research, aid patients, and more!

Donate $10 $15 $20 today to help A Cure in Sight in their quest to find a cure.

Contribute via  PAYPAL OR VENMO or reach out directly to contact@acureinsight.org 
The Eye Believe Podcast is brought to you by Castle Biosciences. Castle Biosciences is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors. 
This podcast was hosted by Danet Peterson and produced by Page Fronczek.